IsoPlexis Corp ISO:NASDAQ

RT Quote | NASDAQ | USD
Last | 08/11/22 EDT
2.15quote price arrow up+0.05 (+2.38%)
Volume
163,889
52 week range
1.62 - 16.95
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.15
  • 52 Week High16.95
  • 52 Week High Date11/19/21
  • 52 Week Low1.62
  • 52 Week Low Date04/27/22

Key Stats

  • Market Cap84.02M
  • Shares Out39.08M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-76.61

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.15
  • 52 Week High16.95
  • 52 Week High Date11/19/21
  • 52 Week Low1.62
  • 52 Week Low Date04/27/22
  • Market Cap84.02M
  • Shares Out39.08M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-76.61

RATIOS/PROFITABILITY

  • EPS (TTM)-2.65
  • P/E (TTM)-0.81
  • Fwd P/E (NTM)-1.33
  • EBITDA (TTM)-87.898M
  • ROE (TTM)-424.74%
  • Revenue (TTM)18.93M
  • Gross Margin (TTM)51.02%
  • Net Margin (TTM)-500.32%
  • Debt To Equity (MRQ)33.92%

EVENTS

  • Earnings Date12/17/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On IsoPlexis Corp

There is no recent news for this security.

Profile

MORE
IsoPlexis Corporation is a life sciences company. The Company is engaged in building solutions to develop curative medicines and personalized therapeutics. The Company's single-cell proteomics systems reveal biological activity in small subsets of cells, allowing researchers to connect directly to in-vivo biology and develop precise and personalized therapies. Its focuses on developing applications of its platform for cancer immunology and cell and gene therapy. The Company's...
John Conley
Non-Executive Independent Chairman of the Board
Sean Mackay
Chief Executive Officer, Co-Founder, Director
John Strahley
Chief Financial Officer
Address
35 Ne Industrial Road
Branford, CT
06405
United States

Top Peers

SYMBOLLASTCHG%CHG
FSTX
F-Star Therapeutics Inc
6.57-0.05-0.76%
SESN
Sesen Bio Inc
0.704+0.0008+0.11%
PIRS
Pieris Pharmaceuticals Inc
1.56-0.02-1.27%
FNCH
Finch Therapeutics Group Inc
2.62+0.02+0.77%
SLGL
Sol Gel Technologies Ltd
6.40+0.29+4.70%